Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boess Carsten
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   125,791    

Indirect Shares

   0      
Direct Value   $5,581,082    

Indirect Value

   $0      
Total Shares   125,791      
Total Value   $5,581,082      


Alexion Pharmaceuticals Inc $912,500 Insulet Corp $3,147,805 Kiniksa Pharmaceuticals, Ltd. $1,423,051 Orchestra BioMed Holdings Inc. $97,726 Alexion Pharmaceuticals Inc $912,500 Insulet Corp $3,147,805 Kiniksa Pharmaceuticals, Ltd. $1,423,051 Orchestra BioMed Holdings Inc. $97,726
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN Former CFO 2005-06-27 5,000 2005-03-09 0    Premium*  
            Insulet Corp PODD Vice President, Intern... 2011-04-25 18,941 2007-12-03 0    Premium*  
            Synageva BioPharma Corp GEVA SVP, Chief Financial O... 2015-06-22 0 2012-07-18 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 10% Owner 2018-05-29 79,589 2018-05-29 0    Premium*  
            Orchestra BioMed Holdings Inc. OBIO Director 2020-08-03 22,261 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OBIO Orchestra BioMed Holdings... Director   –       •      –    2020-08-03 3/A IO $0.00 $0 D/D 0 22,261 -
OBIO Orchestra BioMed Holdings... Director   –       •      –    2020-08-03 3 IO $0.00 $0 D/D 0 20,261 -
KNSA Kiniksa Pharmaceuticals, ... 10% Owner   –       –       •   2018-05-29 4 A $0.00 $0 D/D 6,392 79,589 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2015-06-22 4 D $0.00 $0 D/D (24,000) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2015-06-05 4 A $0.00 $0 D/D 24,000 24,000 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2015-02-17 4 AS $98.85 $4,234,403 D/D (42,297) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2015-02-17 4 OE $1.70 $1,206,485 D/D 42,297 42,297 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-10-30 4 OE $1.70 $206,227 D/D 22,904 22,904 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-10-30 4 AS $80.11 $1,834,839 D/D (22,904) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-10-28 4 AS $80.00 $200,000 D/D (2,500) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-10-28 4 OE $1.70 $25,550 D/D 2,500 2,500 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-05-16 4 AS $81.75 $813,402 D/D (9,927) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-05-16 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-02-18 4 AS $100.07 $1,012,369 D/D (9,927) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-02-18 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-11-18 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-11-18 4 AS $53.98 $546,857 D/D (9,927) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-21 4 AS $47.19 $315,276 D/D (6,681) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-21 4 OE $23.00 $153,663 D/D 6,681 6,681 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-20 4 AS $47.04 $366,912 D/D (7,800) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-20 4 OE $1.70 $59,545 D/D 7,800 7,800 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-16 4 OE $1.70 $7,310 D/D 4,300 4,300 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-16 4 AS $47.47 $204,121 D/D (4,300) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-07-11 4 AS $47.06 $622,933 D/D (13,237) 0 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-07-11 4 OE $1.70 $22,503 D/D 13,237 13,237 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us